Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours (Q46792289)

25 December 2017

title

Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours (English)

1 reference

25 December 2017

Jiafu Ji

7

0 references

author name string

Dong Li Guo

1

1 reference

25 December 2017

Ji Zhang

2

1 reference

25 December 2017

Siu Tsan Yuen

3

1 reference

25 December 2017

Wai Yin Tsui

4

1 reference

25 December 2017

Annie S Y Chan

5

1 reference

25 December 2017

Coral Ho

6

1 reference

25 December 2017

Suet Yi Leung

8

1 reference

25 December 2017

Xin Chen

9

1 reference

25 December 2017

language of work or name

English

0 references

publication date

4 November 2005

1 reference

25 December 2017

published in

Carcinogenesis

1 reference

25 December 2017

volume

27

1 reference

25 December 2017

issue

3

1 reference

25 December 2017

page(s)

454-464

1 reference

25 December 2017

The Eph family: a multitude of receptors that mediate cell recognition signals

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

Eph receptors and ephrin ligands: embryogenesis to tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

APC mutations occur early during colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

Coexpression of ephrin-Bs and their receptors in colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

Expression of Ephb2 and Ephb4 in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

EphB receptor activity suppresses colorectal cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

Inhibition of integrin-mediated cell adhesion but not directional cell migration requires catalytic activity of EphB3 receptor tyrosine kinase. Role of Rho family small GTPases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

EphB2 is a prognostic factor in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

EphB2 as a therapeutic antibody drug target for the treatment of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

Identification of protein-tyrosine kinase genes preferentially expressed in embryo stomach and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

Variation in gene expression patterns in human gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

Ephrins are not only unattractive

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

Eph/Ephrin signaling regulates the mesenchymal-to-epithelial transition of the paraxial mesoderm during somite morphogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

Genomic structure and loss of heterozygosity of EPHB2 in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 2. Identification of small-molecule inhibitors via coupling with virtual screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI259

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGI259

1 reference

25 December 2017

PubMed ID

16272170

1 reference

25 December 2017